EX PARTE APPLICATION OF SANDOZ CANADA INC.

CourtDistrict Court, D. New Jersey
DecidedSeptember 22, 2020
Docket3:20-cv-02425
StatusUnknown

This text of EX PARTE APPLICATION OF SANDOZ CANADA INC. (EX PARTE APPLICATION OF SANDOZ CANADA INC.) is published on Counsel Stack Legal Research, covering District Court, D. New Jersey primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
EX PARTE APPLICATION OF SANDOZ CANADA INC., (D.N.J. 2020).

Opinion

NOT FOR PUBLICATION

UNITED STATES DISTRICT COURT DISTRICT OF NEW JERSEY

In re Ex Parte Application of SANDOZ CANADA, INC. for an Order to Conduct Civil Action No. 20-02425 (MAS) (DEA) Discovery for Use in Foreign Proceedings Pursuant to 28 U.S.C. § 1782 MEMORANDUM OPINION

SHIPP, District Judge This matter comes before the Court upon an ex parte Application by Petitioner Sandoz Canada, Inc. (“Petitioner” or “Sandoz”) for leave to serve a subpoena against Ronald Vladyka ("Vladyka”) pursuant to 28 U.S.C. § 1782. (ECF No. |.) The Court has carefully considered the Petitioner's submission and decides the matter without oral argument pursuant to Local Civil Rule 78.1. For the reasons set forth below, Petitioner’s Application is granted. I. BACKGROUND According to Petitioner’s Application, Hoffmann-La Roche Limited and InterMune, Inc. (collectively, “*Roche”) and Sandoz are engaged in several patent litigations in the Federal Court of Canada, (Pet’r’s Mem. of Law 1, ECF No. I-1.) The Patents in Issue are 2,620,380 ("380 Patent’) and 2,762,013 ("013 Patent’). (/d.) “Each of the Patents in Issue name three inventors: Ronald Vladyka, Ramachandran Radhakrishnan, and Kenneth Sultzbaugh.” (/d.) According to Petitioner. while Ramachandran and Sultzbaugh have been deposed. Vladyka, a resident of

Somerset, New Jersey, “no longer works for Roche” and “has not agreed to produce documents or attend a deposition.” (/d. at 2-3.) Petitioner asserts, “upon information and belief],] .. . Ronald Vladyka has highly relevant information in his possession that pertains to claims in the Canadian patent litigation and that is non-duplicative of the other inventors.” (Jd. at 3.) In order to obtain information from Vladyka, Petitioner applied for and received a “Letter of Request” from the Federal Court of Canada. (Letter of Request. ECF No. 1-5.) The letter from the Canadian court was addressed to the United States District Court for the District of New Jersey and dated November 25, 2019. (/d.) The Letter of Request found that “it appears necessary for the purpose of justice that witnesses residing in your jurisdiction be examined there.” (/e. at 5 (emphasis omitted).} As such, the letter asked this Court to cause Ronald Vladyka to sit for an examination, under oath, and answer questions on certain topics. (dd. at 5.) Furthermore, the letter asks this Court to name a commissioner to conduct the examination. | (id.) The Letter of Request lists the following as topics for Viadyka's examination: I. Background and experience, including pharmaceutical formulation and clinical trials; 2. Preparation of pirfenidone formulations containing a binder; 3. Administration of pirfenidone formulations containing a binder in humans, and collection and analysis of pharmacokinetic parameters; 4, Use of pirfenidone for treating idiopathic pulmonary fibrosis; 5. Administration of capsules of pirfenidone comprising no excipients in humans, and collection and analysis of pharmacokinetic parameters:

While the Federal Court of Canada appears to have contemplated the appointment of a commissioner by the United States District Court for the District of New Jersey who would conduct the examination and help facilitate discovery, Petitioner does not seek such an appointment in the Application now before this Court. Compare Pet’r’s Mem. of Law with in re Meydan Group LLC, No. 15-02141, 2015 WL 2453737, at *1 (D.N.J. May 21, 2015) (appointing an attorney for Meydan as a commissioner for this purpose); Meydan Mem. of Law 1 fare Mevdun Group LLC, 15- cv-02141, ECF No. I-14 (requesting appointment of a Meydan attorney for this purpose).

6. Physical and chemical characterizations of any interaction between pirfenidone and excipients; and 7. Study on the impact of the interaction between pirfenidone and excipients, if any, on pharmacokinetic parameters. (/d. at 6-7.) Moreover, the Federal Court of Canada requested that this Court cause Vladyka to bring and produce at the examination the following documents: 1. Viladyka’s up-to-date curriculum vitae (or resume); 2. Copies of any affidavits or declarations that have been sworn by Ronald Vladyka in any matter relating to the subject-matter of “380 and °013 Patents, or corresponding foreign patents and applications, including United States Patent Nos. US 7,767,225, US 7,988,994, US 8,383,150, US 8,753,679 and Application Publication No. US 2014/242159 and European Patent No. EP 1,940,364 and Application EP 2,431,025; and 3. Copies of documents (including laboratory notebook pages, notes, memoranda, reports, data, correspondence, emails, computer files, and notes of any discussions) relating to the formulation and clinical studies described in the °380 and °013 Patents. (/d. at 5-6.) The Federal Court of Canada further requested that the examination “be scheduled and taken as soon as practically possible following the issuance of the Commission and Letter of Request.” (de, at 7.) Petitioner Sandoz now moves for leave to serve a subpoena seeking the discovery outlined by the Federal Court of Canada in its November 25, 2019 Letter of Request. (See Proposed Subpoena, ECF No. 1-7.) II. LEGAL STANDARD Under Section 1782, “the district court in which a person resides or is found may order him to give his testimony or statement or to produce a document or other thing for use in a proceeding in a foreign or international tribunal.” 28 U.S.C. § 1782(a). Section 1782 aims to “provide

efficient means of assistance to participants in international litigation in our federal courts and encouraging foreign countries by example to provide similar means of assistance to our courts.” in re Mesa Power Group, No. 11-270, 2013 WL 1890222, at *4 (D.N.J. Apr. 19, 2013) (citing Schmitz v. Bernstein, Leibhard & Lifshitz, LLP, 376 F.3d 79, 84 (2d Cir, 2004)). A district court is authorized to grant an application under Section | 782 ifthe following three prima facie statutory requirements are met: 1) the person from whom discovery is sought resides or is found within the district; 2) the discovery is for use in a proceeding before a foreign or international tribunal; and 3) the application is made by a foreign or international tribunal or any interested person. fn re Bayer AG, 146 F.3d 188, 193 (3d Cir. 1998). If the prima facie statutory requirements are met, a district court may, in its discretion, grant the application. Mesa, 2013 WI. 1890222, at *7 (stating that “a district court is not required to grant a Section 1782(a) application simply because it has the authority to do so” (citing /ntel Corp. v. Advanced Micro Devices, Inc., 542 U.S. 241, 264 (2004))). The Supreme Court has identified four discretionary factors that the district court should consider when ruling on a Section 1782(a) request: 1. whether *the person from whom discovery is sought ts a participant in the foreign proceeding,” and thus ‘the need for § 1782(a) aid generally is not as apparent as it ordinarily is when evidence is sought from a nonparticipant in the matter arising abroad’; 2. ‘the nature of the foreign tribunal. the character of the proceedings underway abroad, and the receptivity of the foreign government or the court or agency abroad to U.S. federal-court judicial assistance’; 3. “whether the § 1782(a) request conceals an attempt to circumvent foreign proof gathering restrictions or other policies of a foreign country or the United States’: 4.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Intel Corp. v. Advanced Micro Devices, Inc.
542 U.S. 241 (Supreme Court, 2004)
No. 97-5047
146 F.3d 188 (Third Circuit, 1998)

Cite This Page — Counsel Stack

Bluebook (online)
EX PARTE APPLICATION OF SANDOZ CANADA INC., Counsel Stack Legal Research, https://law.counselstack.com/opinion/ex-parte-application-of-sandoz-canada-inc-njd-2020.